Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04705480 · ClinicalTrials.gov registry record · Phase 4
Pregabalin vs. Gabapentin on Reducing Opioid Usage
A Phase 4 study, sponsored by CAMC Health System.
- Completed
- Registry status
- Phase 4
- Development phase
- 109
- Enrollment target
NCT04705480: Completed Phase 4 study, sponsored by CAMC Health System.
NCT04705480 is a Phase 4 study that has completed, run by CAMC Health System. The registered enrollment target is 109 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04705480, a Phase 4 study, has completed, sponsored by CAMC Health System.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 109 participants
- Enrollment target
Study Summary
This is a single-center, randomized, open-label, Phase 4 clinical trial investigating the efficacy of multiple-dose administrations of Pregabalin or Gabapentin in combination with traditional opioid pain medications to decrease the amount of opioid pain medication usage in single-system orthopedic trauma patients.
Primary Outcome
To determine if adding multiple doses of pregabalin or gabapentin upon admission will reduce opioid usage administered in oral Morphine Milligram Equivalents in trauma patients.
Interventions
- DRUG Pregabalin 50mg
- DRUG Gabapentin 300mg
- DRUG Neither Pregabalin nor Gabapentin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 109 participants |
| Start Date | 2021-04-12 |
| Est. Completion | 2024-12-13 |
| Phase | Phase 4 |
What the finished NCT04705480 record still lists
NCT04705480 is an interventional study that assigns participants to a tested intervention. The registered 109 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (79% lower).
The record links to 0 conditions, and to 3 interventions - of which Pregabalin 50mg is the first listed.
NCT04705480 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04705480 about?
NCT04705480 is a clinical study titled "Pregabalin vs. Gabapentin on Reducing Opioid Usage". This is a single-center, randomized, open-label, Phase 4 clinical trial investigating the efficacy of multiple-dose administrations of Pregabalin or Gabapentin in combination with traditional opioid pain medications to decrease the amount of opioid pain medication usage in single-system orthopedic t...
What is the current status of trial NCT04705480?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 109 participants. The study started on 2021-04-12. Estimated completion is 2024-12-13.
What interventions are being tested in trial NCT04705480?
The interventions under investigation include: Pregabalin 50mg (DRUG), Gabapentin 300mg (DRUG), Neither Pregabalin nor Gabapentin (DRUG).
Who is sponsoring clinical trial NCT04705480?
This trial is sponsored by CAMC Health System, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04705480's enrollment target sits among peer trials
109 737th of 2000 higher than 1,261 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02421380 · 109 participants · NA
Characterization of Hyperpolarized Pyruvate MRI Reproducibility
- NCT04526600 · 109 participants · NA
Fidgeting and Attentional and Emotional Regulation in ADHD
- NCT04835584 · 109 participants · Phase 1
KRT-232 and TKI Study in Chronic Myeloid Leukemia
- NCT06626516 · 109 participants · Phase 1
Tebentafusp-tebn With LDT in Metastatic UM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI